Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway

Multiple Sclerosis

Volumn 15, Issue 8, 2009, Pages 942-950

  Glad, Solveig Bergliot ^a,b   Nyland, H I ^a,b   Aarseth, J H ^a   Riise, T ^a,b   Myhr, K M ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Benign; Clinical; Demographic; Frequency; Long term; Multiple sclerosis; Population based; Prognostic factors

Indexed keywords

ADULT; ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NORWAY; ONSET AGE; PROGNOSIS; RELAPSE; SCORING SYSTEM; SEX DIFFERENCE;

ADULT; AGE FACTORS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROLOGIC EXAMINATION; NORWAY; ODDS RATIO; POPULATION SURVEILLANCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 69549086811     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106511     Document Type: Article

References (44)

1. Glad, S, Nyland, H, Myhr, KM. Benign multiple sclerosis. Acta Neurol Scand Suppl 2006; 183: 55-57.
2. Hawkins, SA, McDonnell, GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67: 148-152.
3. Ramsaransing, GS, De, KJ. Benign course in multiple sclerosis: A review. Acta Neurol Scand 2006; 113: 359-369.
4. Ramsaransing, GS, De, KJ. Predictive value of clinical characteristics for 'benign' multiple sclerosis. Eur J Neurol 2007; 14: 885-889.
5. Sayao, AL, Devonshire, V, Tremlett, H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007; 68: 496-500.
6. Thompson, AJ, Hutchinson, M, Brazil, J, Feighery, C, Martin, EA. A clinical and laboratory study of benign multiple sclerosis. Q J Med 1986; 58: 69-80.
7. Amato, MP, Zipoli, V, Goretti, B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006; 253: 1054-1059.
8. Poser, S, Wikstrom, J, Bauer, HJ. Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system. J Neurol Sci 1979; 40: 159-168.
9. Benedikz, J, Stefansson, M, Guomundsson, J, et al. The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study. Clin Neurol Neurosurg 2002; 104: 208-210.
10. Weinshenker, BG, Bass, B, Rice, GP, et al. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
11. Confavreux, C, Compston, A. The natural history of multiple sclerosis. In: Compston, A, (ed), McAlpines's Multiple Sclerosis, 4th ed. Philadelphia: Churchill Livingstone; 2005. pp. 183-272.
12. Hirst, C, Ingram, G, Swingler, R, Compston, DA, Pickersgill, T, Robertson, NP. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008; 79: 1137-1143.
13. Ramsaransing, G, Maurits, N, Zwanikken, C, De Kayser, J. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 2001; 7: 345-347.
14. Costelloe, L, Thompson, A, Walsh, C, Tubridy, N, Hutchinson, M. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008; 79: 1245-1248.
15. Grytten, N, Glad, SB, Aarseth, JH, Nyland, H, Midgard, R, Myhr, KM. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006; 66: 182-186.
16. Gronning, M, Riise, T, Kvale, G, Albrektsen, G, Midgard, R, Nyland, H. Infections in childhood and adolescence in multiple sclerosis. A case-control study. Neuroepidemiology 1993; 12: 61-69.
17. Myhr, KM, Riise, T, Vedeler, C, et al. Disability and prognosis in multiple sclerosis: Demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001; 7: 59-65.
18. Riise, T, Gronning, M, Aarli, JA, Nyland, H, Larsen, JP, Edland, A. Prognostic factors for life expectancy in multiple sclerosis analysed by cox-models. J Clin Epidemiol 1988; 41: 1031-1036.
19. Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
20. McDonald, WI, Compston, A, Edan, G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
21. Polman, CH, Reingold, SC, Edan, G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
22. Lublin, FD, Reingold, SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-911.
23. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
24. Hosmer, DW, Lemeshow, S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.
25. Miller, D, Weinshenker, B, Filippi, M, et al. Differentialdiagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler 2008; 14: 1157-1174.
26. Phadke, JG. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990; 113: 1597-1628.
27. Confavreux, C, Vukusic, S. Age at disability milestones in multiple sclerosis. Brain 2006; 129: 595-605.
28. Amato, MP, De Stefano, N. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007; 69: 938-939.
29. Pugliatti, M, Riise, T, Nortvedt, MW, et al. Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol 2008; 255: 157-162.
30. Nortvedt, MW, Riise, T, Myhr, KM, Nyland, HI. Quality of life in multiple sclerosis: Measuring the disease effects more broadly. Neurology 1999; 53: 1098-1103.
31. McAlpine, D. Multiple sclerosis: A review. Br Med J 1973; 2: 292-295.
32. McAlpine, D. The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 1961; 84: 186-203.
33. Weinshenker, BG, Rice, GP, Noseworthy, JH, Carriere, W, Baskerville, J, Ebers, GC. The natural history of multiple sclerosis: A geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-1056.
34. Pittock, SJ, McClelland, RL, Mayr, WT, et al. Clinical implications of benign multiple sclerosis: A 20-year population-based follow-up study. Ann Neurol 2004; 56: 303-306.
35. Patti, F, Russo, P, Pappalardo, A, Macchia, F, Civalleri, L, Paolillo, A. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. J Neurol Sci 2007; 252: 121-129.
36. Lauer, K, Firnhaber, W. Prognostic criteria in an epidemiological group of patients with multiple sclerosis: An exploratory study. J Neurol 1992; 239: 93-97.
37. Pittock, SJ, Mayr, WT, McClelland, RL, et al. Change in MS-related disability in a population-based cohort: A 10-year follow-up study. Neurology 2004; 62: 51-59.
38. Fangerau, T, Schimrigk, S, Haupts, M, et al. Diagnosis of multiple sclerosis: Comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand 2004; 109: 385-389.
39. Fox, CM, Bensa, S, Bray, I, Zajicek, JP. The epidemiology of multiple sclerosis in Devon: A comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004; 75: 56-60.
40. De Stefano, N, Battaglini, M, Stromillo, ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006; 129: 2008-2016.
41. Mesaros, S, Rovaris, M, Pagani, E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008; 65: 1223-1230.
42. Calabrese, M, Filippi, M, Rovaris, M, et al. Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study. Mult Scler 2009; 15: 36-41.
43. Gauthier, SA, Berger, AM, Liptak, Z, et al. Rate of brain atrophy in benign vs early multiple sclerosis. Arch Neurol 2009; 66: 234-237.
44. Mandrioli, J, Sola, P, Bedin, R, Gambini, M, Merelli, E. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol 2008; 255: 1023-1031.